Quantum-Si Incorporated - Class A Common Stock (NQ:QSI)

1.430 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Quantum-Si Incorporated - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Tech Stocks AISP, PRSO, QSI, SCKT: $29M DHS Awards, Military Drones, Protein Sequencing Drive Catalysts

October 01, 2026

Via AB Newswire

Topics Artificial Intelligence

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro

September 28, 2026

All measurable sequencing metrics show profound improvement over Platinum Pro

From Quantum-Si Incorporated

Via GlobeNewswire

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

September 15, 2026

Milestone continues the progress towards detection of all 20 amino acids by end of 2026

From Quantum-Si Incorporated

Via GlobeNewswire

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

September 09, 2026

Growing Multi-City Program Continues to Increase Awareness of Proteus and Support Customer Funnel Development Ahead of Commercial Launch

From Quantum-Si Incorporated

Via GlobeNewswire

Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

August 18, 2026

From Quantum-Si Incorporated

Via GlobeNewswire

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

August 13, 2026

From Quantum-Si Incorporated

Via GlobeNewswire

Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026

July 27, 2026

From Quantum-Si Incorporated

Via GlobeNewswire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 16, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™

June 10, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces the Expansion of the Proteus™ Roadshow

June 03, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 13, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones

May 07, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

May 01, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments

April 28, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026

April 16, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting

April 15, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies

April 14, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 10, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System

April 08, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces the Start of the Proteus™ Roadshow

April 06, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 13, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

March 03, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 13, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

February 10, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection

February 05, 2026

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements

December 22, 2025

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 15, 2025

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day

November 20, 2025

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day

November 19, 2025

From Quantum-Si Incorporated

Via Business Wire

Quantum-Si Reports Third Quarter 2025 Financial Results

November 05, 2025

From Quantum-Si Incorporated

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.